Key result
Antihypertensive medicine adherence was positively correlated with both HMSE and MoCA cognitive scores (P<0.001) in older adults with hypertension.
Why the study?
To evaluate the progression of mild cognitive impairment to dementia, examine its relationship with cardiovascular risk factors such as hypertension, and determine the effect of antihypertensive medication adherence on cognitive progression.
Does antihypertensive medication adherence prevent the progression of mild cognitive impairment to dementia in elderly patients with hypertension?
Cohort
Yes
Does antihypertensive medication adherence prevent the progression of mild cognitive impairment to dementia in elderly patients with hypertension?
Antihypertensive medication adherence is positively correlated with better cognitive scores and may help slow the progression of mild cognitive impairment to dementia in elderly patients with hypertension.
Answers are grounded in this paper and cite their sources.
Adherence linked to better cognition in elderly hypertensives; hypothesis-generating for slowing MCI-to-dementia progression.
Objectives: We studied the progression of mild cognitive impairment (MCI) to dementia. The relationship between dementia and several demographic parameters as well as cardiovascular risk factors (mainly hypertension) was also studied. We also ascertained the effect of antihypertensive medication compliance/adherence on the progression of dementia in adults with MCI during a 2-year period. Various biochemical parameters, which can be used as markers, were also examined. Materials and Methods: The investigation was carried out at multispecialty hospitals. The experimental protocol was approved by the ethical committee constituted as per the guidelines of Indian Council of Medical Research. Subjects enrolled were aged ≥50 years and with hypertension ≥5 years. These participants were followed up for 28.69 ± 11.85 months. Subjects were assessed by Hindi Mental State Examination (HMSE) it is a Hindi version of Mini Mental State Examination (MMSE), as well as Montreal Cognitive Assessment (MoCA) test was used for MCI, further assessed by various cognitive domain specific tests. Statistical Analysis: Analysis was done using SPSS (Statistical Package for the Social Sciences) software version 27.0. Results: The mean age of the study sample was 62.41 ± 8.09, with 45% of the population belonging to a rural background. Executive function was most affected. Age was negatively correlated with HMSE score ( P < 0.05), whereas education and medicine adherence were positively correlated with both HMSE and MoCA scores ( P < 0.001). Conclusion: Slowing down the rate of dementia progression is critical in developing economies to avoid the devastating economic and social burden that dementia causes. This can be achieved by managing dementia risk factors and implementing a comprehensive cognitive assessment in susceptible subjects (such as hypertension). Blood biomarkers can be beneficial in conjunction with early and easy diagnosis (MCI) and treatment.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2025) conducted a cohort in Mild cognitive impairment and hypertension. Antihypertensive medication adherence was evaluated on HMSE and MoCA scores (p=<0.001). Antihypertensive medicine adherence was positively correlated with both HMSE and MoCA cognitive scores (P<0.001) in older adults with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: